Core A: Administrative
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1U19AI181881-01
Grant search
Key facts
Disease
UnspecifiedStart & end year
20242027Known Financial Commitments (USD)
$2,769,693Funder
National Institutes of Health (NIH)Principal Investigator
Lynda StuartResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF WASHINGTONResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY - CORE A: ADMINISTRATIVE The Administrative Core will coordinate the scientific, administrative, and financial functions of our multi-project, multi-institution Center. It will ensure that the Center, and the work therein, performs as a cohesive and coordinated entity to maximize the impact of the associated investigators. It will build on the long-running, highly productive collaborations between the Project and Core leads and leverage the experienced administrative infrastructure at UW's Institute for Protein Design, led by Dr. Lynda Stuart, to meet the needs of the Center. The Administrative Core is a central unit overseeing and supporting all Center components (five Projects, five Cores) and will ensure that the scientific team remains focused on the main goal of the Center: to develop generalizable strategies for paramyxovirus and bunyavirus vaccine design. The Core leadership will also ensure effective communication between other ReVAMPP Centers and the NIH programmatic staff. The goals of the Core will be: 1) to provide organizational governance and oversight to the Center, 2) to ensure effective and efficient communication and collaboration between the Center members, and 3) to maximize the engagement between our Center and the broader scientific community, including the other ReVAMPP Centers.